Xvivo Perfusion AB (publ) (STO:XVIVO)

Sweden flag Sweden · Delayed Price · Currency is SEK
196.70
-0.20 (-0.10%)
Aug 5, 2025, 5:29 PM CET
-0.10%
Market Cap6.20B
Revenue (ttm)822.93M
Net Income (ttm)111.38M
Shares Out31.50M
EPS (ttm)3.50
PE Ratio56.25
Forward PE49.46
Dividendn/a
Ex-Dividend Daten/a
Volume164,388
Average Volume259,123
Open197.70
Previous Close196.90
Day's Range193.30 - 199.00
52-Week Range193.30 - 541.00
Beta1.96
RSI31.20
Earnings DateJul 11, 2025

About United States Steel

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi... [Read more]

Sector Healthcare
Founded 1998
Employees 190
Stock Exchange Nasdaq Stockholm
Ticker Symbol XVIVO
Full Company Profile

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.

Financial Statements

News

Xvivo Perfusion AB (XVIPF) Q2 2025 Earnings Call Highlights: Navigating Challenges and Seizing ...

Xvivo Perfusion AB (XVIPF) Q2 2025 Earnings Call Highlights: Navigating Challenges and Seizing Growth Opportunities

24 days ago - GuruFocus

Q2 2025 Xvivo Perfusion AB Earnings Call Transcript

Q2 2025 Xvivo Perfusion AB Earnings Call Transcript

24 days ago - GuruFocus